IL17A and ulcerative colitis: In colonic biopsies from patients with active ulcerative colitis, treatment with OLE significantly reduced the expression of the inflammatory markers COX-2 and IL-17, as well as the IL-17 levels in culture supernatants, suggesting anti-inflammatory effects in the colonic mucosa of ulcerative colitis patients [26].